ConductScience.org, home

Paper8911291

Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.

Nickel JC and 6 others. CMAJ, 1996. Cited by 187 papers, by iCite.

Cite this record

ConductScience Library. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study. Papers, record 8911291. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8911291

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.
PubMed
Journal
CMAJ
PubMed
Year
1996
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
187
iCite
Relative citation ratio, by iCite
7.22
iCite
Revised in PubMed
2018-11-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nickel JCJ C
2Fradet YY
3Boake RCR C
4Pommerville PJP J
5Perreault JPJ P
6Afridi SKS K
7Elhilali MMM M

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Enzyme InhibitorsMajor topic
FinasterideMajor topic
Prostatic HyperplasiaMajor topic
Aged
Aged, 80 and over
Canada
Double-Blind Method
Humans
Male
Middle Aged
Prospective Studies
Safety
Urination

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in9099163Managing benign prostatic hyperplasia.https://conductscience.org/library/papers/9099163

Source PubMed

Download CSV of comments and corrections

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12428671Comparison of the alpha-adrenoceptor characteristics in human and canine prostate.Fed Proc1986https://conductscience.org/library/papers/2428671PubMed
24130099A urodynamic view of prostatic obstruction and the results of prostatectomy.Br J Urol1973https://conductscience.org/library/papers/4130099PubMed
34413434Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.N Engl J Med1974https://conductscience.org/library/papers/4413434PubMed
48633398A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia.Urology1996https://conductscience.org/library/papers/8633398PubMed
58558668Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men.J Urol1996https://conductscience.org/library/papers/8558668PubMed
67527493
A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate.
N Engl J Med1995https://conductscience.org/library/papers/7527493PubMed
77510911Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia.Urology1994https://conductscience.org/library/papers/7510911PubMed
87505563Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. The Finasteride Study Group.Arch Intern Med1994https://conductscience.org/library/papers/7505563PubMed
97686980Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia.J Urol1993https://conductscience.org/library/papers/7686980PubMed
101283370Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia.Eur Urol1992https://conductscience.org/library/papers/1283370PubMed
111383816The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.N Engl J Med1992https://conductscience.org/library/papers/1383816PubMed
122643719Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients.J Urol1989https://conductscience.org/library/papers/2643719PubMed
134384673The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.J Biol Chem1968https://conductscience.org/library/papers/4384673PubMed

Download CSV of references

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 187 citations.

PMIDTitleJournalYearIn PapersSource
42492846Steroid 5α-reductases in the brain: From neurosteroidogenesis to therapeutic implications.Front Neuroendocrinol2026https://conductscience.org/library/papers/42492846PubMed
42041803Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment.Brain Sci2026https://conductscience.org/library/papers/42041803PubMed
37697052The post-finasteride syndrome: possible etiological mechanisms and symptoms.Int J Impot Res2025https://conductscience.org/library/papers/37697052PubMed
37002313Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study.Sci Rep2023https://conductscience.org/library/papers/37002313PubMed
36580423Adrenal Steroids and Resistance to Hormonal Blockade of Prostate and Breast Cancer.Endocrinology2023https://conductscience.org/library/papers/36580423PubMed
36086755
Effectiveness and safety of electroacupuncture and its cotreatment with electronic moxibustion in the treatment of patients with moderate benign prostatic hyperplasia using alpha blocker: An assessor-blinded, randomized, controlled pilot study.
Medicine (Baltimore)2022https://conductscience.org/library/papers/36086755PubMed
34949831The placebo and nocebo effects in functional urology.Nat Rev Urol2022https://conductscience.org/library/papers/34949831PubMed
34747724Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis.Asian J Androl2022https://conductscience.org/library/papers/34747724PubMed
34729231
The effect of pharmacotherapy on prostate volume, prostate perfusion and prostate-specific antigen (prostate morphometric parameters) in patients with lower urinary tract symptoms and benign prostatic obstruction. A systematic review and meta-analysis.
Cent European J Urol2021https://conductscience.org/library/papers/34729231PubMed
32435662Post-finasteride syndrome: An emerging clinical problem.Neurobiol Stress2020https://conductscience.org/library/papers/32435662PubMed
32314009The impact of 5-alpha-reductase inhibitors on mortality in a prostate cancer chemoprevention setting: a meta-analysis.World J Urol2021https://conductscience.org/library/papers/32314009PubMed
32124221Are Noninvasive Methods Comparable to Liver Biopsy in Postoperative Patients After Roux-en-Y Gastric Bypass?Obes Surg2020https://conductscience.org/library/papers/32124221PubMed
32052367Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function.Endocrine2020https://conductscience.org/library/papers/32052367PubMed
31272082Altered methylation pattern of the SRD5A2 gene in the cerebrospinal fluid of post-finasteride patients: a pilot study.Endocr Connect2019https://conductscience.org/library/papers/31272082PubMed
29909472The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.Curr Urol Rep2018https://conductscience.org/library/papers/29909472PubMed
29675596Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?Endocrine2018https://conductscience.org/library/papers/29675596PubMed
29527813Effect of lower urinary tract symptoms on the quality of life and sexual function of males in China, Taiwan, and South Korea: Subgroup analysis of a cross-sectional, population-based study.Low Urin Tract Symptoms2019https://conductscience.org/library/papers/29527813PubMed
29264229Medical therapy for clinical benign prostatic hyperplasia: α1 Antagonists, 5α reductase inhibitors and their combination.Asian J Urol2017https://conductscience.org/library/papers/29264229PubMed
28956697Annurca Apple Nutraceutical Formulation Enhances Keratin Expression in a Human Model of Skin and Promotes Hair Growth and Tropism in a Randomized Clinical Trial.J Med Food2018https://conductscience.org/library/papers/28956697PubMed
28232919Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome.Skin Appendage Disord2017https://conductscience.org/library/papers/28232919PubMed

See all 53 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8911291

GET https://conductscience.org/api/papers/v1/8911291/cited_by?page=2